<110>    L-Base Co., Ltd.

<120>    Novel oligopeptides and pharmaceutical composition for preventing
         or treating cancer comprising the same as an active ingredient

<130>    MPCT20-037

<150>    US 62/842,155
<151>    2019-05-02

<160>    6

<170>    KoPatentIn 3.0

<210>    1
<211>    8
<212>    PRT
<213>    Artificial Sequence

<220>
<223>    Oligopeptide #1 AQTITGKT


<400>    1
Ala Gln Thr Ile Thr Gly Lys Thr
  1               5            


<210>    2
<211>    8
<212>    PRT
<213>    Artificial Sequence

<220>
<223>    Oligopeptide #2 AQTLTGKT


<400>    2
Ala Gln Thr Leu Thr Gly Lys Thr
  1               5            


<210>    3
<211>    8
<212>    PRT
<213>    Artificial Sequence

<220>
<223>    Oligopeptide #3 AQTATGKT


<400>    3
Ala Gln Thr Ala Thr Gly Lys Thr
  1               5            


<210>    4
<211>    8
<212>    PRT
<213>    Artificial Sequence

<220>
<223>    Oligopeptide #4 AQTMTGKT


<400>    4
Ala Gln Thr Met Thr Gly Lys Thr
  1               5            


<210>    5
<211>    8
<212>    PRT
<213>    Artificial Sequence

<220>
<223>    Oligopeptide #5 AQTPTGKT


<400>    5
Ala Gln Thr Pro Thr Gly Lys Thr
  1               5            


<210>    6
<211>    8
<212>    PRT
<213>    Artificial Sequence

<220>
<223>    Oligopeptide #6 AQTVTGKT


<400>    6
Ala Gln Thr Val Thr Gly Lys Thr
  1               5            
